Updated:
Navam Capital
Navam is a venture capital firm focused on making seed and early-stage investments in frontier technology and science-driven innovation. It invests in...
Navam Capital
Navam is a venture capital firm focused on making seed and early-stage investments in frontier technology and science-driven innovation. It invests in engineering-driven ventures that transform old industries and create new ones, backing founders who bring the future into the present. The firm partners with founders early and supports entrepreneurs through formative stages, providing unique venture assistance across science, technology, business operations, and investment.
General information
Firm type
Venture Capital
Year founded
2008
Location
Region
Asia
Country
India
City
Kolkata
Corporate office
Kolkata, India
Principals
Rajeev Mantri
Founder and Managing Partner
Anjan Ray
Investment Partner
Shiladitya Sengupta
Venture Advisor
Tarun Mehta
Venture Advisor
Ramesh Mangaleswaran
Senior Advisor and Operating Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Navam Capital?
Founder and Managing Partner Rajeev Mantri leads investment decisions. He is supported by Investment Partner Anjan Ray and a network of Venture Advisors that includes Harvard Medical School professor Shiladitya Sengupta and Ather Energy CEO Tarun Mehta, both of whom bring active operating and scientific experience to deal evaluation.
How does Navam Capital source proprietary deal flow?
Navam sources heavily from India's elite technical institutes — the Indian Institutes of Technology and the Indian Institute of Science. Portfolio companies such as Agnikul Cosmos, Vayudh, and Morphing Machines originated from these institutions. Investment Partner Anjan Ray's tenure as Director of CSIR-IIP and Senior Advisor Ramesh Mangaleswaran's three-decade McKinsey network extend that reach into national laboratories and industrial research.
Does Navam Capital participate in fund commitments or only direct deals?
The firm focuses on direct seed and early-stage equity investments. It does not publicly disclose a fund-of-funds or LP commitment program, and based on its stated strategy of being frequently the first investor, the emphasis is on direct company exposure.
What investment stages does Navam Capital typically target?
Navam targets seed and early-stage opportunities. The firm describes itself as frequently the first institutional investor in a venture, which puts its typical entry point before Series A.
How is Navam Capital related to Vyome Therapeutics?
Founder Rajeev Mantri co-founded biopharma venture Vyome Therapeutics and served as its president during the company's formative years. Venture Advisor Shiladitya Sengupta is also a Vyome co-founder. The firm does not list Vyome's current status as a Navam portfolio company, but the connection reflects the partnership's deep operating history in biotech.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: